Atlas Trials

Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Clinical trial NCT03342261 · COMPLETED

Trial details

NCT number
NCT03342261
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis C, ChronicMixed Cryoglobulinemia
Start date
2017-03-01
Primary completion
2017-11-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.